Nerve Blocks for Breast Surgery Pain
Trial Summary
What is the purpose of this trial?
This trial tests new methods to improve pain management and recovery for patients undergoing breast surgery. The goal is to reduce pain, potentially leading to quicker hospital discharge and better overall patient care.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you use opioids daily over 30 mg of oxycodone or equivalent, you may not be eligible to participate.
What data supports the effectiveness of this treatment for breast surgery pain?
Is the nerve block treatment for breast surgery pain generally safe for humans?
How does the nerve block treatment for breast surgery pain differ from other treatments?
This treatment is unique because it uses nerve blocks like the Parasternal Block (PSB) and Thoracic Transversus Plane Block (TTP) to specifically target and relieve pain in the internal mammary region, which other common nerve blocks like the Pectoral Nerve Block (PECS) and Serratus Plane Block (SPB) do not effectively address.12489
Research Team
Abhijit Biswas, MD
Principal Investigator
London Health Sciences Center, Western University, London. Ontario. Canada
Eligibility Criteria
This trial is for women aged 18-70, with a physical status classified as ASA I to III, undergoing bilateral breast reduction surgery as a day procedure. It's not specified who can't join the trial.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Management
Participants receive preoperative ultrasound-guided nerve blocks and standard monitoring
Intraoperative Management
Participants undergo surgery with standardized general anesthesia and nerve blocks
Postoperative Management
Participants receive postoperative pain management and are monitored for recovery
Follow-up
Participants are monitored for safety and effectiveness after treatment, including pain and recovery assessments
Treatment Details
Interventions
- Bilateral parasternal infrapectoral block (Procedure)
- Bilateral serratus plane block (Procedure)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Western University, Canada
Lead Sponsor
Dr. Robin Farias-Eisner
Western University, Canada
Chief Executive Officer since 2022
PhD in Molecular Biology from UCLA, MD from the Royal College of Surgeons in Dublin, MBA from Pepperdine University
James Tweedy
Western University, Canada
Chief Medical Officer since 2020
MBA from Trinity Western University